We are live on ! Find out more
TGI

TRV GP III Portfolio holdings

AUM $6.14M
1-Year Est. Return 45.44%
This Fund
S&P 500
This Quarter Est. Return
+75.98%
1 Year Est. Return
+45.44%
3 Year Est. Return
+169.98%
5 Year Est. Return
+802.39%
10 Year Est. Return
–
AUM
$226M
AUM Growth
+$50M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
5.8 quarters
Top 10 Avg Time Held
5.8 quarters
Top 20 Avg Time Held
5.8 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
FULC icon
1
Fulcrum Therapeutics
FULC
$288M
$99.2M 43.81%
5,962,202
– –
2019 Q3
1 quarter
VYGR icon
2
Voyager Therapeutics
VYGR
$151M
$89.2M 39.37%
6,391,176
– –
2017 Q4
8 quarters
JNCE
3
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$26.6M 11.75%
3,048,780
– –
2017 Q4
8 quarters
NTGN
4
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$11.5M 5.08%
9,741,636
– –
2018 Q2
6 quarters

Similar funds

TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

TRV GP III's Q4 2019 Portfolio in Review

As of Q4 2019, TRV GP III held 4 positions worth $226M, up 28% from $176M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 0%. TRV GP III opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP III's ten largest holdings make up 100% of its $226M portfolio in Q4 2019.
  • TRV GP III opened 0 new positions and closed 0 in Q4 2019.
  • TRV GP III's portfolio value rose 28% quarter-over-quarter to $226M.

Based on TRV GP III's 13F filing for Q4 2019, filed 5 Feb 2020.